Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Genome binding/occupancy profiling by high throughput sequencing | Hongjian Jin | ||||||
GSE108344 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [ChIP-seq]
|
|
59 | Hongjian Jin | Jan 03, 2019 | |||
GSE108364 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects
|
|
100 | Hongjian Jin | Jan 03, 2019 | |||
GSE115872 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [ChIP-Seq]
|
|
80 | Hongjian Jin | Mar 18, 2019 | |||
GSE115875 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
|
|
130 | Hongjian Jin | Mar 18, 2019 | |||
GSE151493 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [ChIP-seq]
|
|
12 | Hongjian Jin | Dec 22, 2020 | |||
GSE151598 |
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy
|
|
21 | Hongjian Jin | Dec 22, 2020 | |||
GSE164504 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam (ATAC-Seq)
|
|
6 | Hongjian Jin | Nov 24, 2021 | |||
GSE164506 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam
|
|
34 | Hongjian Jin | Nov 24, 2021 | |||
GSE157092 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [ATAC-seq]
|
|
14 | Hongjian Jin | Sep 06, 2022 | |||
GSE157093 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [CUT&RUN]
|
|
18 | Hongjian Jin | Sep 06, 2022 | |||
GSE157094 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [ChIP-seq]
|
|
28 | Hongjian Jin | Sep 06, 2022 | |||
GSE157095 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma
|
|
104 | Hongjian Jin | Sep 06, 2022 | |||
GSE198752 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [ChIP-Seq, 2]
|
|
8 | Hongjian Jin | Sep 06, 2022 | |||
GSE198753 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]
|
|
18 | Hongjian Jin | Sep 06, 2022 | |||
GSE198754 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&Tag]
|
|
10 | Hongjian Jin | Sep 06, 2022 | |||
GSE218274 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
|
|
75 | Hongjian Jin | Sep 29, 2023 | |||
GSE218265 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Cut&Run]
|
|
15 | Hongjian Jin | Sep 30, 2023 | |||
GSE164456 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
69 | Hongjian Jin | Mar 02, 2024 | |||
GSE207035 |
KDM4 histone lysine demethylases maintain the adrenergic core regulatory circuitry programed by MYCN in neuroblastoma
|
|
30 | Hongjian Jin | Mar 02, 2024 | |||
GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
26 | Hongjian Jin | Mar 02, 2024 |